tiprankstipranks
Kazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq Listing
Company Announcements

Kazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq Listing

Kazia Therapeutics (KZIA) has released an update.

Don't Miss our Black Friday Offers:

Kazia Therapeutics plans to modify the ratio of its American Depositary Shares (ADS) to improve its trading price on Nasdaq, with the new ratio set to take effect on October 28, 2024. This change aims to help the company meet Nasdaq’s minimum bid price requirement, but there is no guarantee it will succeed. The adjustment will not affect the number of underlying Ordinary Shares, and the company’s stock will continue to trade under the ticker symbol ‘KZIA.’

For further insights into KZIA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskKazia Therapeutics Secures Nasdaq Compliance
TheFlyKazia Therapeutics management to meet with Maxim
TipRanks Auto-Generated NewsdeskKazia Therapeutics Advances Paxalisib with FDA Meeting
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App